» Articles » PMID: 39421083

A Ticking Time Bomb: A Case Report of Neutropenic Fever Secondary to Tick-Borne Illness

Overview
Journal Cureus
Date 2024 Oct 18
PMID 39421083
Authors
Affiliations
Soon will be listed here.
Abstract

The advent of immunomodulatory therapies and their ever-expanding number of treatment indications necessitates the understanding of their associated complications. Neutropenic fever serves as an example of these complications often encountered in clinical practice. Although neutropenic fever can result from virtually any pathogen, episodes of the syndrome secondary to tick-borne illness remain relatively undocumented in the scientific literature. In the case presented, a 77-year-old female with a pertinent past medical history of smoldering IgG multiple myeloma on active immunosuppressive therapy presented with a first-time episode of neutropenic fever likely secondary to tick-borne illness. Through this report, attention is drawn to an additional source pathogen for neutropenic fever and its management, thus expanding upon clinician understanding of this all-too-common complication of immunosuppression.

References
1.
Beard C, Eisen L, Eisen R . The Rise of Ticks and Tickborne Diseases in the United States-Introduction. J Med Entomol. 2021; 58(4):1487-1489. PMC: 9620473. DOI: 10.1093/jme/tjab064. View

2.
Joyner G, Mavin S, Milner R, Lim C . Introduction of IgM testing for the diagnosis of acute Lyme borreliosis: a study of the benefits, limitations and costs. Eur J Clin Microbiol Infect Dis. 2022; 41(4):671-675. PMC: 8934319. DOI: 10.1007/s10096-021-04366-4. View

3.
Freifeld A, Bow E, Sepkowitz K, Boeckh M, Ito J, Mullen C . Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america. Clin Infect Dis. 2011; 52(4):e56-93. DOI: 10.1093/cid/cir073. View

4.
Martinson M, Lapham J . Prevalence of Immunosuppression Among US Adults. JAMA. 2024; 331(10):880-882. PMC: 10870224. DOI: 10.1001/jama.2023.28019. View

5.
Diaz-Tejedor A, Lorenzo-Mohamed M, Puig N, Garcia-Sanz R, Mateos M, Garayoa M . Immune System Alterations in Multiple Myeloma: Molecular Mechanisms and Therapeutic Strategies to Reverse Immunosuppression. Cancers (Basel). 2021; 13(6). PMC: 8002455. DOI: 10.3390/cancers13061353. View